Sphere Bio in China
Sphere Bio Expands Operations in China
Sphere Bio
PR-06-25-NI-04Jun 17, 2025
BIOSECURE Act
Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?
Pharma's Almanac
PAO-11-24-RT-01Oct 28, 2024
Drug Supply
BeiGene Announces Supply Update for ABRAXANE in China
BeiGene
PR-M03-20-NI-037Mar 25, 2020
Drug Development
WuXi Biologics Congratulates Tychan on the World’s First Yellow Fever Antibody Tested Safe and Efficacious in Human Volunteers
WuXi Biologics
PR-M11-19-NI-018Nov 19, 2019
China
GE Healthcare Life Sciences and Akeso Pharmaceuticals to Speed Up Novel Therapy Manufacturing in China
Nice Insight
PR-M11-19-NI-015Nov 15, 2019
Strategic Collaboration
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
Amgen
PR-M10-19-NI-048Nov 01, 2019
R&D
Covance Unveils New R&D Center in Shanghai
LabCorp
PR-M09-19-NI-038Sep 16, 2019
M&A
Zhejiang Jiuzhou to Acquire Suzhou Unit of Novartis AG for CNY790 Million
Nice Insight
PAO-M09-19-NI-009Sep 05, 2019
Licensing Agreement
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
Innovent
PR-M08-19-NI-076Aug 27, 2019
Collaboration
iBio and CC-Pharming Expand Business Collaboration in China
iBio, Inc.
PR-M08-19-NI-087Aug 26, 2019
Research
Hybrid Human/Monkey Embryos Created by Salk Researchers in China
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-027Aug 22, 2019
Drug Pricing
China Welcomes Indian Competition in Push to Lower Drug Costs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-010Aug 07, 2019
Generics
China Eases Generic Drug Market Shake-Up
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-001Aug 01, 2019
Biosimilars
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China
Celltrion, Inc.
PR-M07-19-NI-058Jul 23, 2019
Gene Editing
China to Introduce Regulations on Gene Editing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M05-19-NI-031May 29, 2019
Consumer Healthcare
GSK and Pfizer’s Combined Consumer Healthcare Business Will Focus on the U.S. and China
Pharma's Almanac
PAO-M04-19-NI-016Apr 10, 2019
Oncology Drugs
China Cancer Drugs Market 2018-2024: Rising Demand of Targeted Drug Therapy and the Patent Expiration of Key Cancer Drugs
ResearchandMarkets
PR-M01-19-NI-044-3143Jan 16, 2019
New Facility
Pall Opens Center of Excellence in Shanghai
Pall Corporation
PR-M12-18-NI-080Dec 27, 2018
Immunotherapy
I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy
I-Mab
PR-M11-18-NI-014Nov 05, 2018
Investment
Foreign Investment: Chinese Capital Backs U.S. Biotech
Emilie Branch
Pharma's Almanac
PAP-Q4-18-NI-008Oct 26, 2018